Bibliography - Disposable Bioprocessing Systems - page 279

PQRI Leachables and Extractables Working Group. Safety Thresholds and Best
Practices for Extractables and Leachables in Orally Inhaled and Nasal Drug
Products. Product Quality Research Institute: Arlington, VA; http://www.pqri.
org/pdfs/LE_Recommendations_to_FDA_09-29-06.pdf . 2006.
Prashad, M. and Tarrach, K. 2006. Depth filtration aspects for the clarification of CHO
cell derived biopharmaceutical feed streams. FISE 9: 28-30.
Press/BioPlan Associates, 1-28.
Product Quality Research Institute
Proulx, S.P. and Furey, J.F. 2007. Disposable, pre-sterilized fluid receptacle sampling
device. 7293477 B2, Millipore Corporation, USA.
Purefit data sheet FLS-3309A-1.5M-1008-SGCS. Saint-Gobain Performance Plastics
2008.
Quattroflow. 2010. Catalogue. Available: http://www.quattrolow.com/055c079b
5a0c11315/index.html .
Rafa, B. and Panofen, F. 2009. Reprásentativ und kontaminations-frei. P&A Biotech 1:
37.
Ransohoff, T. 2004. Disposable chromatography: Current capabilities and future pos-
sibilities. BPD North Carolina Biotechnology Center, November 18.
Rao, G., Moreira, A., and Brorson, K. 2009. Disposable bioprocessing: The future has
arrived. Biotechnol. Bioeng. 102(2): 348-356.
Rathore, N. and Rajan, R.S. 2008. Current perspectives on stability of protein drug
products during formulation, fill and finish operations. Biotechnol. Prog . 24 (3):
504-514.
Rauth, A.M. 1965. The physical state of viral nucleic acid and the sensitivity of viruses
to ultraviolet light. Biophys. J . 5: 257-273.
Raval, K., Liu, C.M., and Büchs, J. 2006. Large-scale disposable shaking bioreactors.
BioProcess Int . 1: 46-49.
Ravise, A. et al. 2010. Hybrid and disposable facilities for manufacturing of biophar-
maceuticals: Pros and cons. Adv. Biochem. Eng. Biotechnol . 115: 185-219. DOI: ID
1007/10_2008_24.
Rawlings, B. and Pora, H. 2009. Environmental impact of single-use and reusable
bioprocess systems. BioProcess Int . 2: 18-25.
Ray, S. and Tarrach, K. 2008. Virus clearance strategy using a three-tier orthogonal
technology platform. BioPharm Int . 22: 50-58.
Reactor development for the hepatitis A vaccine VAQTA. In: Carrondo, M.J.T.,
Griffiths, B., and Moreira, J.L.P. (eds.), Animal Cell Technology: From Vaccine to
Genetic Medicine . Kluwer, Dordrecht, pp. 175-183.
Reardon, K.F., Scheper, T., Anders, K.D., Muller, W., and Buckmann, A.F. 1989. Novel
applications of fluorescence sensors. 11th Symposium on Biotechnology for
Fuels and Chemicals, Colorado Springs, CO.
Reardon, K.F., Scheper, T., and Bailey, J.E. 1986. In situ fluorescence monitoring of
immobilized Clostridium acetobutylicum . Biotechnol. Lett . 8 (11): 817-822.
Reardon, K.F., Scheper, T.H., and Bailey, J.E. 1987. Use of a fluorescence sensor for
measurement of NAD(P)H-dependent culture fluorescence of immobilized cell
systems. Chemie Ingenieur Technik 59 (7): 600-601.
Reif, O.W., Solkner, P., and Rupp, J. 1996. Analysis and evaluation of filter cartridge
extractables for validation of pharmaceutical downstream processing. J. Pharm.
Sci. Technol . 50: 399-407.